异动解读 | Ginkgo Bioworks Holdings盘前暴跌12.63%,每股亏损2美元远超预期引发抛售

异动解读
26 Feb

Ginkgo Bioworks Holdings(DNA)今早在盘前交易中股价大跌12.63%,引发了市场的广泛关注。

根据公司发布的2024年第四季度财报,该公司当季度每股亏损高达2美元,远高于分析师预期的1.77美元亏损水平。同时该公司当季度营收为4385万美元,也未能达到市场预期的4446万美元。

尽管相比上年同期,公司本季度亏损和营收数据均有所改善,但未能实现分析师的预期目标,令投资者对其未来增长前景失去信心,从而引发股价大跌。分析人士表示,如果公司下一季度业绩无法扭转颓势,该股价或将面临进一步下跌的风险。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10